Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-548 for Acute Pain After Abdominoplasty
NCT05034952Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suzetrigine in acute pain, sponsored by Vertex Pharmaceuticals. Started Aug 2021; status: completed.
02
Drugs
suzetrigine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05034952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05034952.